Susquehanna International Group, LLP Ultragenyx Pharmaceutical Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 120,460 shares of RARE stock, worth $4.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,460

Previous 180,425 33.24%

Holding current value

$4.23 Million

Previous $7.59 Million 42.54%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$36.21 - $45.78 $2.17 Million - $2.75 Million	-59,965 Reduced 33.24%	120,460 $4.36 Million
Q4 2024 Feb 14, 2025	BUY	$42.07 - $57.72 $2.53 Million - $3.47 Million	60,088 Added 49.93%	180,425 $7.59 Million
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $3.84 Million - $5.67 Million	95,466 Added 383.84%	120,337 $6.68 Million
Q2 2024 Aug 15, 2024	SELL	$37.42 - $51.61 $901,036 - $1.24 Million	-24,079 Reduced 49.19%	24,871 $1.02 Million
Q1 2024 May 07, 2024	BUY	$43.02 - $53.69 $576,855 - $719,929	13,409 Added 37.73%	48,950 $2.29 Million
Q4 2023 Feb 14, 2024	SELL	$31.73 - $49.19 $2.9 Million - $4.5 Million	-91,516 Reduced 72.03%	35,541 $1.7 Million
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $572,443 - $764,897	16,393 Added 14.81%	127,057 $4.53 Million
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $1.42 Million - $1.98 Million	37,951 Added 52.19%	110,664 $5.1 Million
Q1 2023 May 16, 2023	BUY	$36.99 - $48.71 $2.16 Million - $2.84 Million	58,324 Added 405.34%	72,713 $2.92 Million
Q4 2022 Feb 14, 2023	SELL	$33.72 - $46.33 $2.61 Million - $3.58 Million	-77,300 Reduced 84.31%	14,389 $666,000
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $3.52 Million - $5.83 Million	88,154 Added 2493.75%	91,689 $3.8 Million
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $747,364 - $1.39 Million	-16,318 Reduced 82.19%	3,535 $211,000
Q1 2022 May 16, 2022	SELL	$62.2 - $84.4 $466,997 - $633,675	-7,508 Reduced 27.44%	19,853 $1.44 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $758,402 - $903,991	10,289 Added 60.27%	27,361 $2.3 Million
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $6.69 Million - $8.79 Million	-85,845 Reduced 83.41%	17,072 $1.54 Million
Q2 2021 Aug 11, 2021	BUY	$92.19 - $115.71 $8.63 Million - $10.8 Million	93,594 Added 1003.9%	102,917 $9.81 Million
Q1 2021 May 17, 2021	SELL	$106.9 - $167.73 $381,205 - $598,125	-3,566 Reduced 27.67%	9,323 $1.06 Million
Q4 2020 Feb 16, 2021	SELL	$84.4 - $177.39 $69,123 - $145,282	-819 Reduced 5.97%	12,889 $1.78 Million
Q3 2020 Nov 16, 2020	SELL	$72.98 - $90.0 $2.06 Million - $2.54 Million	-28,174 Reduced 67.27%	13,708 $1.13 Million
Q2 2020 Aug 14, 2020	SELL	$46.91 - $78.22 $2.29 Million - $3.83 Million	-48,907 Reduced 53.87%	41,882 $3.28 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $707,839 - $1.32 Million	20,942 Added 29.98%	90,789 $4.03 Million
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $298,598 - $379,289	-8,276 Reduced 10.59%	69,847 $2.98 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $1.3 Million - $1.93 Million	30,548 Added 64.21%	78,123 $3.34 Million
Q2 2019 Aug 16, 2019	BUY	$54.93 - $74.36 $2.34 Million - $3.17 Million	42,614 Added 858.98%	47,575 $3.02 Million
Q2 2019 Aug 14, 2019	SELL	$54.93 - $74.36 $1.83 Million - $2.48 Million	-33,309 Reduced 87.04%	4,961 $315,000
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $261,963 - $520,692	6,736 Added 21.36%	38,270 $1.66 Million
Q3 2018 Nov 14, 2018	SELL	$71.81 - $90.15 $143,763 - $180,480	-2,002 Reduced 5.97%	31,534 $2.41 Million
Q1 2018 May 15, 2018	SELL	$44.33 - $58.52 $2.61 Million - $3.44 Million	-58,792 Reduced 63.68%	33,536 $1.71 Million
Q4 2017 Feb 14, 2018	BUY	$43.54 - $57.32 $4.02 Million - $5.29 Million	92,328	92,328 $4.28 Million

Others Institutions Holding RARE

# of Institutions

336

Shares Held

88.9M

Call Options Held

1.08M

Put Options Held

1.04M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.46B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Ultragenyx Pharmaceutical Inc. Transaction History